Evidence map›Paper›PMID 16024779›Full record

ArticleMolecular and cellular biology2005

JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2).

Dianzheng Zhang, Ho-Guen Yoon, Jiemin Wong

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. JMJD family proteins in cancer and inflammation.Signal transduction and targeted therapy · 2022
    Review
  7. Article
  8. Article
  9. Mechanistic insights into KDM4A driven genomic instability.Biochemical Society transactions · 2021
    Review
  10. Article
  11. Review
  12. The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy.Frontiers in cell and developmental biology · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. POWERDRESS and HDA9 interact and promote histone H3 deacetylation at specific genomic sites in Arabidopsis.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Dianzheng ZhangDepartment of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030.
Ho-Guen Yoon
Jiemin Wong
Baylor College of Medicine · US

Funding

CHARACTERIZATION OF COREPRESSOR N-COR COMPLEXESR01DK058679 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI WONG, JIEMIN · 2001 to 2005
$1.2M
THYROID HORMONE RECEPTOR ACTION IN CHROMATINR01DK056324 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI WONG, JIEMIN · 1999 to 2003
$947k
NIDDK NIH HHS DK56324NIDDK NIH HHS DK58679NIDDK NIH HHS R01 DK056324NIDDK NIH HHS R01 DK058679
6 · The paper itself

Abstract

Corepressor N-CoR (nuclear receptor corepressor) and the highly related protein SMRT (silencing mediator of retinoid and thyroid hormone receptor) play important roles in different biological processes including proliferation, differentiation, and development. Understanding the biological function of these corepressors requires identification and characterization of their interacting proteins. Here we report the characterization of a novel N-CoR-interacting protein, JMJD2A (previously known as KIAA0677). JMJD2A is an evolutionarily conserved nuclear protein containing many functionally unknown domains. JMJD2A directly interacts with the N-terminal region of N-CoR through a small NID (N-CoR interaction domain) both in vitro and in vivo. Despite its copurification with N-CoR, JMJD2A is not a core subunit of the stable multiprotein N-CoR complex and is not required for N-CoR-mediated repression by thyroid hormone receptor. By chromatin immunoprecipitation cloning, we identified the human achaete scute-like homologue 2 (ASCL2/Hash2) gene as a gene regulated by JMJD2A. ASCL2 is a basic helix-loop-helix transcription factor whose mouse homolog is encoded by an imprinted gene highly expressed during the development of extraembroynic trophoblast lineages but repressed in other tissues and is essential for proper placental development. We demonstrated that JMJD2A selectively represses the expression of the ASCL2 gene but not other imprinted genes in the same imprinted locus in HeLa cells and that this repression required a functional N-CoR complex and the tandem Tudor domain of JMJD2A. Like N-CoR, JMJD2A is widely expressed in various mouse tissues. Our data indicate that JMJD2A makes use of the N-CoR complex to repress transcription and suggest that JMJD2A together with N-CoR could play a role in repressing ASCL2 expression in various tissues.

Indexed as

Basic Helix-Loop-Helix ProteinsCell NucleusDNA-Binding ProteinsGene Expression ProfilingGene Expression RegulationGenomic ImprintingHistone Deacetylase 3Histone DeacetylasesHumansJumonji Domain-Containing Histone DemethylasesNuclear ProteinsNuclear Receptor Co-Repressor 1Oxidoreductases, N-DemethylatingProtein Structure, TertiaryReceptors, Thyroid HormoneRepressor ProteinsASCL2 protein, humanBasic Helix-Loop-Helix ProteinsDNA-Binding ProteinsHistone Deacetylase 3Histone DeacetylasesJumonji Domain-Containing Histone DemethylasesKDM4A protein, humanNCOR1 protein, humanNcor1 protein, mouseNuclear ProteinsNuclear Receptor Co-Repressor 1Oxidoreductases, N-DemethylatingReceptors, Thyroid HormoneRepressor ProteinsTranscription Factors

Identifiers

PMID16024779
PMCPMC1190321
OpenAlexW2150085673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.